Uncovering the Mechanism of the Effects of Pien-Tze-Huang on Liver Cancer Using Network Pharmacology and Molecular Docking

Abstract EN

Pien-Tze-Huang (PTH) has a long history in the treatment of liver cancer.

However, its molecular mechanism of action remains unclear.

TCMSP and TCM were used to collect the active ingredients.

Bioactive compounds targets were predicted by reverse pharmacophore models.

The antiliver cancer targets of PTH were selected by gene comparison of liver cancer in the GEO database.

Molecular docking was used to verify the binding activity of the targets and the active ingredients.

The DAVID was used to analyze the gene function and signal pathway.

A model was built with Cytoscape.

The core genes were obtained by PPI network.

We screened the 4 main medicinal ingredients of PTH to obtain 16 active ingredient, 190 potential targets, and 6 core genes.

We found that active small molecules exert anticancer effects by multiple pathways.

The core genes were involved in multiple biological processes.

We also found that eight chemical components play a greater role in inhibiting liver cancer.

PTH achieves the effect of inhibiting liver cancer through the synergistic effect of multiple components, multiple targets, and multiple pathways.

This study provides a potential scientific basis for further elucidating the molecular mechanism of action of PTH against liver cancer.